# Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation.

> **NCT02457247** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 276 (actual)

## Conditions studied

- Calcium and Vitamin D Deficiencies

## Interventions

- **DRUG:** Calcichew D3
- **DRUG:** Adcal-D3
- **DRUG:** Kalcipos-D

## Key facts

- **NCT ID:** NCT02457247
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2016-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02457247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02457247, "Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02457247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*